Package Leaflet: Information for the Patient
Fesoterodina Teva 4 mg prolonged-release tablets EFG
fesoterodine fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet. You may need to read it again.
Contents of the pack
Fesoterodina Teva contains the active substance fesoterodine fumarate and is a treatment called an antimuscarinic, which reduces the activity of the overactive bladder and is used in adults to treat the symptoms.
Fesoterodina treats the symptoms of an overactive bladder, such as:
Do not take fesoterodine if:
Warnings and precautions
Fesoterodina may not always be suitable for you. Talk to your doctor before taking Fesoterodina in any of the following cases:
Heart problems: Inform your doctor if you have any of the following conditions:
Children and adolescents
Do not give this medicine to children and adolescents under 18 years of age because it has not been established whether it works and is safe for them.
Other medicines and Fesoterodina Teva
Tell your doctor or pharmacist if you are taking or have recently taken or may need to take other medicines. Your doctor will tell you if you can use fesoterodine with other medicines.
Please inform your doctor if you are taking medicines from the list below. Taking these medicines at the same time as fesoterodine may cause side effects such as dry mouth, constipation, difficulty emptying the bladder completely, or more severe or frequent drowsiness than usual.
Please indicate to your doctor if you are taking any of the following medicines:
Pregnancy, breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take fesoterodine if you are pregnant, as the effects of fesoterodine on pregnancy and the newborn are unknown.
It is unknown whether fesoterodine is excreted in breast milk; therefore, do not breastfeed during treatment with fesoterodine.
Driving and using machines
Fesoterodine may cause blurred vision, dizziness, and drowsiness. If you experience any of these effects, do not drive or operate tools or machines.
Fesoterodina Teva contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially, "sodium-free".
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended initial dose of fesoterodine is one 4 mg tablet per day. Depending on how you respond to the medicine, your doctor may prescribe a higher dose; one 8 mg tablet per day.
Swallow the tablet whole with a glass of water. Do not chew the tablet. Fesoterodine can be taken with or without food.
To help you remember to take your medicine, it may be easier to take it at the same time every day.
If you take more Fesoterodina Teva than you should
If you have taken more tablets than you should or if someone else has taken your tablets, contact your doctor or hospital immediately. Show them the pack of tablets.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Fesoterodina Teva
If you have forgotten to take a tablet, take it as soon as you remember, but do not take more than one tablet in a day. Do not take a double dose to make up for forgotten doses.
If you stop taking Fesoterodina Teva
Do not stop taking Fesoterodina Teva without talking to your doctor first, as the symptoms of an overactive bladder may return or worsen when you stop taking Fesoterodina Teva.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious
Rarely, severe allergic reactions may occur, including angioedema. You should stop taking fesoterodine and contact your doctor immediately if you develop swelling in the face, mouth, or throat, as this can be life-threatening.
Other side effects
Very common(may affect more than 1 in 10 people):
You may notice dry mouth. This effect is usually mild or moderate. This may increase the risk of tooth decay. Therefore, you should brush your teeth regularly, twice a day, and visit a dentist if you have any doubts.
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) via their website: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after "EXP". The expiry date is the last day of the month shown.
Fesoterodina Teva 4 mg:
Do not store above 30°C.
Keep the blister perfectly closed to protect it from moisture.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for proper disposal. This will help protect the environment.
Composition of Fesoterodina Teva
The active substance is fesoterodine fumarate.
Fesoterodina Teva 4 mg prolonged-release tablets EFG
Each prolonged-release tablet contains 4 mg of fesoterodine fumarate, equivalent to 3.1 mg of fesoterodine.
The other ingredients are:
Core of the tablet: dibehenate of glycerol, hypromellose, talc, lactose monohydrate (see section 2 "Fesoterodina Teva contains lactose and sodium"), and microcrystalline cellulose
Coating: polyvinyl alcohol, talc, titanium dioxide (E171), glycerol monocaprylate, sodium lauryl sulfate, and aluminum lake crimson (E132)
Appearance and packaging
Fesoterodina Teva 4 mg prolonged-release tablets EFG
The 4 mg film-coated tablets are light blue, oval, biconvex, and engraved with the number "4" on one side.
Fesoterodina Teva is available in packs of 10, 14, 20, 28, 30, 40, 42, 50, 56, 60, 70, 80, 84, 90, 98, 100 prolonged-release tablets in perforated and non-perforated OPA/Alu/PVC-Aluminum blisters.
Not all pack sizes may be marketed.
Marketing authorization holder
Teva B.V.
Swensweg 5
2031GA Haarlem
Netherlands
Manufacturer
Rontis Hellas, Medical and Pharmaceutical Products S.A.,
Larissa Industrial Area, P.O. Box 3012,
Larissa, 41 500,
Greece
You can obtain further information on this medicine from the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edifício Albatros B, 1ª planta,
Alcobendas, 28108, Madrid (Spain)
Date of last revision of this leaflet:June 2024
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es
The average price of FESOTERODINE TEVA 4 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 17.87 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.